Cytotoxicity and antitumour activity of 5-fluorouracil-loaded polyhydroxybutyrate and cellulose acetate phthalate blend microspheres

References

• Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: Preliminary findings. Cancer Lett 1987; 37: 147–51
   PubMed Web of Science ®Google Scholar
• Bowers LD. Kinetic plasma creatinine assays I: The role of various factors in determining specificity. Clin Chem 1980; 26: 551–4
   PubMed Web of Science ®Google Scholar
• Bradley DW, Maynard JE, Emery G, Webster H. Transaminase activities in serum of long-term hemodialysis patients. Clin Chem 1972; 18: 1442
   PubMed Web of Science ®Google Scholar
• Chabner BA, Allegra CJ, Curt GA, Calabresi P. Anti-neoplastic agents. Goodman and Gilman's the pharmacological basis of therapeutics, JG Hardman, LE Limbird, PM Berry, WR Raymond. McGraw-Hill, New Delhi 1996; 1233–87
   Google Scholar
• Chaturvedi K, Kulkarni AR, Aminabhavi TM. Blend microspheres of poly(3-hydroxybutyrate) and cellulose acetate phthalate for colon delivery of 5-fluorouracil. Ind Eng Chem Res 2011; 50: 10414–23
   Web of Science ®Google Scholar
• Copur S, Aiba K, Drake JC, Allegra CJ, Chu E. Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil. Biochem Pharmacol 1995; 49: 1419–26
   PubMed Web of Science ®Google Scholar
• Dev RK, Bali V, Pathak V. Novel microbially triggered colon specific delivery system of 5-fluorouracil: Statistical optimization, in vitro, in vivo, cytotoxic and stability assessment. Int J Pharm 2011; 411: 142–51
   PubMed Web of Science ®Google Scholar
• Djordjeuic B, Lange CS, Allison RR, Rotman M. Response of primary colon cancer cells in hybrid spheroids to 5-fluorouracil. Cancer Invest 1993; 11: 291–3
   PubMed Web of Science ®Google Scholar
• Doumas BT, Byase DD, Carter RJ, Theodore Jr P, Schaffer R. A candidate reference method for determination of total protein in plasma I: Development and validation. Clin Chem 1981; 27(10)1642–50
   PubMed Web of Science ®Google Scholar
• Fiala ES. Investigation into metabolism and mode of action of the colon carcinogen 1,2-dimethylhydrazine and azoxymethane. Cancer 1977; 40: 2436–45
   PubMed Web of Science ®Google Scholar
• Fiala ES, Sohn OS, Hamilton SR. Effects of chronic dietary ethanol on the in vivo and in vitro metabolism of methylazoxymethanol and on methylazoxymethanol induced DNA methylation in the rat colon and liver. Cancer Res 1987; 47: 5939–43
   PubMed Web of Science ®Google Scholar
• Fischel JL, Etienne MC, Spector T, Formento P, Renee N, Milano G. Dihydropyrimidine dehydrogenase: A tumoral target for fluorouracil modulation. Clin Cancer Res 1995; 1: 991–6
   PubMed Web of Science ®Google Scholar
• Francis D, Rita L. Rapid colorometric assay for cell growth and survival modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986; 89: 271–7
   PubMed Web of Science ®Google Scholar
• Freshney I. Culture of animal cells. Wiley-Liss, New York 1994
   Google Scholar
• Ganguly K, Aminabhavi TM, Kulkarni AR. Colon targeting of 5-fluorouracil using polyethylene glycol cross-linked chitosan microspheres enteric coated with cellulose acetate phthalate. Ind Eng Chem Res 2011; 50: 11797–807
   Web of Science ®Google Scholar
• Herrmann R. Systemic treatment of colorectal cancer. Eur J Cancer 1993; 29A: 583–6
   PubMed Web of Science ®Google Scholar
• Ishikawa T, Utoh M, Sawada N, Nishida M, Fukase Y, Sekiguchi F, Ishitsuka H. Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts. Biochem Pharmacol 1998; 55: 1091–7
   PubMed Web of Science ®Google Scholar
• Jain A, Gupta Y, Jain SK. Potential of calcium pectinate beads for target specific drug release to colon. J Drug Target 2007; 15: 285–94
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69–90
   PubMed Web of Science ®Google Scholar
• Labianca RF, Beretta GD, Pessi MA. Colorectal cancer: Disease management considerations. Drugs 2001; 61: 1751–64
   PubMed Web of Science ®Google Scholar
• LaMont JT, O’Gorman TA. Experimental colon cancer. Gastroenterology 1978; 75: 1157–69
   PubMed Web of Science ®Google Scholar
• Li W, Li CB. Lack of inhibitory effect of lactic acid bacteria on 1,2-dimethylhydrazine-induced colon tumors in rat. World J Gastroenterol 2003; 9: 2469–73
   PubMed Web of Science ®Google Scholar
• Meropol NJ. Oral fluoropyrimidines in the treatment of colorectal cancer. Eur J Cancer 1998; 34: 1509–13
   PubMed Web of Science ®Google Scholar
• Moss DW, Henderson AR. Clinical enzymology. Tietz textbook of clinical chemistry, CA Burtis, ER Ashwood. WB Saunders Co, Philadelphia, PA 1999; 617–721
   Google Scholar
• Mundargi RC, Patil SA, Agnihotri SA, Aminabhavi TM. Development of polysaccharide-based colon targeted drug delivery systems for the treatment of amoebiasis. Drug Dev Ind Pharm 2007; 33: 255–64
   PubMed Web of Science ®Google Scholar
• Nykänen P, Sten T, Jürjenson H, Veski P, Marvola M. Citric acid as a pH-regulating additive in granules and the tablet matrix in enteric-coated formulations for colon-specific drug delivery. Pharmazie 2004; 59: 268–73
   PubMedGoogle Scholar
• Preezel NC, Webling DDA. The length and mucosal surface area of the small and large gut in young rat. J Anat 1971; 108: 295–6
   PubMed Web of Science ®Google Scholar
• Rahman Z, Kohli K, Zhang SQ, Khar RK, Ali M, Charoo NA, Tauseef M, Shamsher AA, Mohammed NN, Repka MA. In-vivo evaluation in rats of colon-specific microspheres containing 5-fluorouracil. J Pharm Pharmacol 2008; 60: 615–23
   PubMed Web of Science ®Google Scholar
• Routledge ED, Gorman S, Clark MR. Cell and tissue culture: Laboratory procedures. Wiley, New York 1994
   Google Scholar
• Sandle GI. Salt and water absorption in the human colon: A modern appraisal. Gut 1998; 43: 294–9
   PubMed Web of Science ®Google Scholar
• Shishu Gupta N, Aggarwal N. Stomach-specific drug delivery of 5-fluorouracil using floating alginate beads. AAPS PharmSciTech 2007; 8: E1–7
   PubMedGoogle Scholar
• Tuǧcu-Demiröz F, Acartürk F, Takka S. Investigation of colon-specific dosage forms of ondansetron prepared with natural polymers. Pharmazie 2006; 61: 916–19
   PubMed Web of Science ®Google Scholar
• Wei H, Qing D, De-Ying C, Bai X, Li-Fang F. Study on colon-specific pectin/ethylcellulose film-coated 5-fluorouracil pellets in rats. Int J Pharm 2008; 348: 35–45
   PubMed Web of Science ®Google Scholar
• Wu B, Deng D, Lu Y, Wu W. Biphasic release of indomethacin from HPMC/pectin/calcium matrix tablet: II. Influencing variables, stability and pharmacokinetics in dogs. Eur J Pharm Bipharm 2008; 69: 294–302
   PubMed Web of Science ®Google Scholar
• Yan C, Gu J, Guo Y, Chen D. In vivo biodistribution for tumor targeting of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) nanoparticles. Yakugaku Zasshi 2010; 130: 801–4
   PubMed Web of Science ®Google Scholar
• Yang L, Chu JS, Fix JA. Colon-specific drug delivery: New approaches and in vitro/in vivo evaluation. Int J Pharm 2002; 235: 1–15
   PubMed Web of Science ®Google Scholar
• Yoon SS, Eto H, Lin CM, Nakamura H, Pawlik TM, Song SU, Tanabe KK. Mouse endostatin inhibits the formation of lung and liver metastasis. Cancer Res 1999; 59: 6251–6
   PubMed Web of Science ®Google Scholar
• Zambito Y, Baggiani A, Carelli V, Serafini MF, Di Colo G. Matrices for site-specific controlled-delivery of 5-fluorouracil to descending colon. J Control Release 2005; 102: 669–77
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huo M, Zhou J, Xie S. PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Meth Prog Biol 2010; 99: 306–14
   PubMed Web of Science ®Google Scholar
• Zinutti C, Barberi-Heyob M, Hoffman M, Maincent P. In-vivo evaluation of sustained release microspheres of 5-FU in rabbits. Int J Pharm 1998; 166: 231–4
   Web of Science ®Google Scholar